key: cord-0885303-pcuumc1o
authors: Pacifico, A.; Ardigò, M.; Frascione, P.; Damiani, G.; Morrone, A.
title: Phototherapeutic approach to dermatological patients during the 2019 Coronavirus pandemic: Real‐life Data from the Italian Red Zone
date: 2020-04-17
journal: Br J Dermatol
DOI: 10.1111/bjd.19145
sha: 65af09c67d9da99693286f07930594d0ace70a56
doc_id: 885303
cord_uid: pcuumc1o

Since the novel Coronavirus 2019, also known as COVID‐19 or SARS CoV‐2, crossed the Chinese borders and became pandemic, Italy has rapidly become the country with the highest number of patient deaths as well as confirmed and/or hospitalized patients, after China [1‐2]. On March 12(th) Italy was declared a red‐zone and special protocols were enacted to limit the spread of the virus. Although COVID‐19 does not have epidermotropism, cutaneous manifestations in Cov‐19 positive patients have been reported [3] and departments of dermatology are considered at high risk [4] and were ordered to admit only patients needing urgent treatments or undergoing chronic immunosuppressive therapy in order to minimize nosocomial virus spread.

To the Editor, Since the novel Coronavirus 2019, also known as COVID-19 or SARS CoV-2, crossed the Chinese borders and became pandemic, Italy has rapidly become the country with the highest number of patient deaths as well as confirmed and/or hospitalized patients, after China [1] [2] . On March 12 th Italy was declared a red-zone and special protocols were enacted to limit the spread of the virus. Although COVID-19 does not have epidermotropism, cutaneous manifestations in Cov-19 positive patients have been reported [3] and departments of dermatology are considered at high risk [4] and were ordered to admit only patients needing urgent treatments or undergoing chronic immunosuppressive therapy in order to minimize nosocomial virus spread.

Hence, it is crucial to maintain phototherapy services for immunosuppressed dermatological patients that cannot access other treatments, especially during the COVID-19 emergency. The To minimize CoV-19 exposure, a new internal protocol based on 3Ts was applied [ Figure 1 ]:

-Telemedicine: patients that will attend the service the next day undergo a phone call pre-triage (telemedicine) in which HR ask the presence of fever (temperature 37.5 °C or 99.5°F) sore throat, rhinorrhea, cough, cold and flu-like symptoms, contact with patients confirmed or in quarantine for COVID-19, or recent trips (<14 days) to other high risk countries;

This article is protected by copyright. All rights reserved -Triage: if patients pass the pre-triage, they are authorized to access the hospital and they undergo a secondary face-to-face triage verifying the pre-triage CoV-19 criteria;

-Treatment: after preliminary physician examination, the patients undergo phototherapy (UVA1 or NB UVB) delivered only by ramps equipped with 13 UVB TL01 lamps (Philips® TL100 W/01 fluorescent tubes) and not by booths that are difficult to sanitize. Both HR and dermatologists go into another room and communicate with the patient using a microphone and speaker system to minimize contact. Ramps and the entire treatment room are sanitized by cleaning all the surfaces with a hydro-alcohol solution containing glutaraldeyde after each patient, including the floor up to 1 meter from the lamps. HR and physicians wash their hands and brush the sub-nail region after each patient. Any HR in direct contact with patients wear the suggested personal protective equipment (PPE) (mask model N95 with a FFP2 filter protecting, gloves and protective glasses) [5] . Patients are encouraged to wear the provided mask entering the phototherapy area and to remove it only during the treatment. Everyone is instructed to maintain safety distance of 2-3 meters.

Patients suspected of the COVID-19 infection are tested. In confirmed cases, patients can receive prescription after undergoing a teledermatological evaluation from home via Skype. Patients with a negative test result can do triage in dermatology.

Since this protocol does not permit us to perform the same number of visits normally given, we were forced to assign priorities based on disease morbidity, severity and risk or erythroderma (dermatological emergency). Thus, we decided to interrupt NB UVB in vitiligo patients and switch them to self-application of tacrolimus ointment (0.1% for lesions located in resistant sites and 0.03% for sensitive areas, including eyelids) plus systemic antioxidants to continue melanocyte stimulation previously triggered by phototherapy. Then, in psoriasis patients we opted to maintain NB UVB only in patients with PASI>10 or in patients with psoriasis rupiacea.

Conversely patients with PASI<10 were switched to topical corticosteroids and, if highly keratotic we added a keratolytic agent. Due to the well-known immunosuppressive effects of PUVA [6] , all patients undergoing this treatment were shifted to NB UVB with or without retinoids. Poorly infiltrated but generalized parapsoriasis and mycoses fungoides patients continue NB UVB. In atopic dermatitis, only patients with EASI >10 or SCORAD>30 continue phototherapy and did not

This article is protected by copyright. All rights reserved switch to topical corticosteroids, in particular patients undergoing UVA1 are switched to NB UVB in order to decrease the number of visits (5 vs. 3) and also because UVA1 beds are difficult to efficiently sanitize. All scleroderma patients undergoing UVA1 were switched to topical corticosteroids. After these decisions only 38 patients will continue NB UVB (31 with psoriasis, 10 with Parapsoriasis / Mycosis Fungoides and 3 with Atopic dermatitis).

In conclusion during COVID-19 emergency, we believe that phototherapy represents an important resource for treating immunosuppressed at-risk dermatological patients, HR and dermatologists should carefully follow COVID-19 preventive recommendations.

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response

Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department

Consensus of Chinese experts on protection of skin and mucous membrane barrier for healthcare workers fighting against coronavirus disease

Immunosuppression in phototherapy

Figure legend Figure 1: Admission 3T (Telemedicine, Triage, Treatment) protocol to the phototherapy

We thank Professor Thomas McCormick for the editing and suggestions.

This article is protected by copyright. All rights reserved

bjd_19145_f1.tiff